β2‐adrenoreceptor medications and risk of Parkinson disease

Overview of attention for article published in Annals of Neurology, October 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 3 X users

f1000: 1 research highlight platform

Readers on

mendeley: 94 Mendeley
citeulike: 1 CiteULike

So far, Altmetric has seen 5 X posts from 3 X users, with an upper bound of 58,468 followers.

Curious result as it has previously been report that there is a very strong positive association between #Parkinsons & use of the non-β2-active tremor medication primidone prior to PD diagnosis https://t.co/Uys06VLYZw

This new study supports last years findings, but clashes with a recent case-control study of US Medicare beneficiaries which FAILED to find an association after removing tremor treatment & smoking from the analysis. Not sure if new study checked this …

Recent study observed a 2x greater risk of #Parkinson in users of β2-adrenoreceptor antagonist propranolol & a lower risk of PD for the β2-adrenoreceptor agonist salbutamol. BUT new case-control study of US Medicare beneficiaries FAILS to replicate re…

β2-adrenoreceptor medications and risk of Parkinson disease. https://t.co/3qLc6HnuLD

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 1 additional X posts.